Japan OK’s Pfizer Vaccine for XBB.1.5 Omicron Variant

The Pfizer logo is seen at an office in Belgium in December 2022.
15:05 JST, September 2, 2023
The Health, Labor and Welfare Ministry gave special approval for the manufacture and sale of Pfizer Inc.’s vaccine for XBB.1.5, a new omicron variant of the novel coronavirus, in Japan on Friday.
Those 6 months or older will be eligible to receive the U.S. pharmaceutical company’s vaccine. Inoculations will begin on Sept. 20 in preparation for the expected spread of coronavirus infections during the year-end and New Year’s holidays.
The shots will be administered for free during fiscal 2023.
"Society" POPULAR ARTICLE
-
World War II Battleship Yamato Was Outdated From the Start; Unable to Compete With Newly Developed Warplanes
-
Nankai Trough Megaquake Estimated Death Toll Lowered, Tsunami-hit Area Increased in Govt Report
-
Cherry Blossoms Reach Full Bloom in Tokyo; Ueno Park Draws Many Viewers
-
Cherry Blossoms Officially in Bloom in Tokyo, Beating Last Year’s Date by 5 Days
-
2025 Expo Osaka: Tokyo Police on High Alert Ahead of Opening; Officials Cautious over Possibility of Lone Offenders, Cyberattacks
JN ACCESS RANKING